Latest filing published 25 Jun 2025 for SynAct Pharma AB, €4,375.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Jeppe Oevlesen: trading record in brief
Jeppe Oevlesen appears in our data through filings on SynAct Pharma AB shares, published by Finansinspektionen. Between 3 June 2024 and 25 June 2025, the trades on record add up to 3 filings.
On the market, this insider has only ever bought: 2 purchases, €31k in total. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 1 share grant. 2025 to date brings 2 purchases and no sales.
The latest filing, published on 25 June 2025, reports an open-market purchase of €4,375 in SynAct Pharma AB. The median gap between a trade and its publication by Finansinspektionen is 2 days. Under the Market Abuse Regulation, managers have three business days to notify their trades. Source: insider filings from Finansinspektionen. Past trades are no guide to future returns.
Companies and markets linked to Jeppe Oevlesen
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,757 shares@ SEK 17.55114.1% of flowAktieISIN SE0008241491FI:csv-47e738e580020ca39d47Canonical exit: 23 Sept 2025 (T+90)
- 18,500 shares@ SEK 16.044385.9% of flowAktieISIN SE0008241491FI:csv-7f9d118a08c250077574Canonical exit: 17 Sept 2025 (T+90)
- 722,688 shares0OptionISIN SE0008241491FI:csv-6f769bd50870433bfeec
3 of 3 declarations